Literature DB >> 20303362

Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons.

Keri N Althoff1, Kathryn Anastos, Kenrad E Nelson, David D Celentano, Gerald B Sharp, Ruth M Greenblatt, Audrey L French, Don J Diamond, Susan Holman, Mary Young, Stephen J Gange.   

Abstract

OBJECTIVE: To estimate the cumulative incidence of self-reported influenza vaccination ("vaccination coverage") and investigate predictors in HIV-infected women.
METHODS: In an ongoing cohort study of HIV-infected women in five US cities, data from two influenza seasons (2006-2007 n=1209 and 2007-2008 n=1161) were used to estimate crude and adjusted prevalence ratios (aPR) and 95% confidence intervals ([,]) from Poisson regression with robust variance models using generalized estimating equations (GEE).
RESULTS: In our study, 55% and 57% of HIV-infected women reported vaccination during the 2006-2007 and 2007-2008 seasons, respectively. Using data from both seasons, older age, non-smoking status, CD4 T-lymphocyte (CD4) count > or =200 cells/mm(3), and reporting at least one recent healthcare visit was associated with increased vaccination coverage. In the 2007-2008 season, a belief in the protection of the vaccine (aPR=1.38 [1.18, 1.61]) and influenza vaccination in the previous season (aPR=1.66 [1.44, 1.91]) most strongly predicted vaccination status.
CONCLUSION: Interventions to reach unvaccinated HIV-infected women should focus on changing beliefs about the effectiveness of influenza vaccination and target younger women, current smokers, those without recent healthcare visits, or a CD4 count <200 cells/mm(3). Copyright (c) 2010 The Institute For Cancer Prevention. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303362      PMCID: PMC2883293          DOI: 10.1016/j.ypmed.2010.03.007

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  39 in total

1.  Racial similarities in response to standardized offer of influenza vaccination. A MetroNet study.

Authors:  Kendra L Schwartz; Anne Victoria Neale; Justin Northrup; Joseph Monsur; Divya A Patel; Rodrigo Tobar; Pascale M Wortley
Journal:  J Gen Intern Med       Date:  2006-04       Impact factor: 5.128

2.  Relationship between prevalence rate ratios and odds ratios in cross-sectional studies.

Authors:  C Zocchetti; D Consonni; P A Bertazzi
Journal:  Int J Epidemiol       Date:  1997-02       Impact factor: 7.196

3.  Prevention and control of influenza.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1988-06-17       Impact factor: 17.586

4.  Compromised B cell responses to influenza vaccination in HIV-infected individuals.

Authors:  Angela Malaspina; Susan Moir; Susan M Orsega; Joshua Vasquez; Natalie J Miller; Eileen T Donoghue; Shyamasundaran Kottilil; Misrak Gezmu; Dean Follmann; Galina M Vodeiko; Roland A Levandowski; JoAnn M Mican; Anthony S Fauci
Journal:  J Infect Dis       Date:  2005-03-24       Impact factor: 5.226

5.  Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients.

Authors:  Hikaru Yamanaka; Katsuji Teruya; Mari Tanaka; Yoshimi Kikuchi; Takao Takahashi; Satoshi Kimura; Shinichi Oka
Journal:  J Acquir Immune Defic Syndr       Date:  2005-06-01       Impact factor: 3.731

6.  Influenza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season.

Authors:  H M Radwan; S H Cheeseman; K K Lai; R T Ellison III
Journal:  Clin Infect Dis       Date:  2000-08       Impact factor: 9.079

7.  Retention of women enrolled in a prospective study of human immunodeficiency virus infection: impact of race, unstable housing, and use of human immunodeficiency virus therapy.

Authors:  N A Hessol; M Schneider; R M Greenblatt; M Bacon; Y Barranday; S Holman; E Robison; C Williams; M Cohen; K Weber
Journal:  Am J Epidemiol       Date:  2001-09-15       Impact factor: 4.897

8.  Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata.

Authors:  Richard Kent Zimmerman; Mahlon Raymund; Janine E Janosky; Mary Patricia Nowalk; Michael J Fine
Journal:  Vaccine       Date:  2003-03-28       Impact factor: 3.641

9.  Influenza-associated hospitalizations in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Carolyn B Bridges; Nancy J Cox; Keiji Fukuda
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

10.  Influenza immunization for HIV-infected persons in Los Angeles.

Authors:  F J Sorvillo; B L Nahlen
Journal:  Vaccine       Date:  1995-03       Impact factor: 3.641

View more
  7 in total

1.  Assessing influenza vaccination coverage and predictors in persons living with HIV/AIDS in Louisiana, June 2002-June 2013.

Authors:  Patrick Maloney; Ariane Rung; Stephanie Broyles; John Couk; Edward Peters; Susanne Straif-Bourgeois
Journal:  J Prev Med Hyg       Date:  2022-04-26

Review 2.  Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy.

Authors:  Meghan E Fitzpatrick; Ken M Kunisaki; Alison Morris
Journal:  AIDS       Date:  2018-01-28       Impact factor: 4.177

3.  The coverage of influenza and pneumococcal vaccinations among people living with HIV in Denmark: A single-center cross-sectional survey.

Authors:  Lykke Larsen; Mai Thanh Thuy Nguyen; Isik Somuncu Johansen
Journal:  Hum Vaccin Immunother       Date:  2021-03-24       Impact factor: 3.452

4.  Vaccine uptake and barriers to vaccination among at-risk adult populations in the US.

Authors:  Irina Kolobova; Mawuli Kwame Nyaku; Anna Karakusevic; Daisy Bridge; Iain Fotheringham; Megan O'Brien
Journal:  Hum Vaccin Immunother       Date:  2022-05-10       Impact factor: 4.526

Review 5.  Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005 - 2016.

Authors:  Philipp Schmid; Dorothee Rauber; Cornelia Betsch; Gianni Lidolt; Marie-Luisa Denker
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

6.  Sociodemographic, HIV-Related Characteristics, and Health Care Factors as Predictors of Self-Reported Vaccination Coverage in a Nationwide Sample of People Aging with HIV in Germany.

Authors:  Jochen Drewes; Phil C Langer; Jennifer Ebert; Dieter Kleiber; Burkhard Gusy
Journal:  Int J Environ Res Public Health       Date:  2021-05-04       Impact factor: 3.390

7.  System factors to explain 2009 pandemic H1N1 state vaccination rates for children and high-risk adults in US emergency response to pandemic.

Authors:  Carlo Davila-Payan; Julie Swann; Pascale M Wortley
Journal:  Vaccine       Date:  2013-11-25       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.